FDA Inspection 1293412 — Xuchen Cao
The FDA completed an inspection of Xuchen Cao on Nov 21, 2025 in Tianjin. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 21, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tianjin (China)
Additional Details
Clinical Investigator (CI)